Evaxion A/S
Evaxion utilizes its AI-Immunology™ platform to challenge and improve standardized treatments. In oncology, they create personalized therapies, tailoring treatment to the individual. For infectious diseases, they design next-generation vaccines to address unmet medical needs. Their AI platform accelerates vaccine target discovery, design, and development.
Official Registry
Last verified: 1/2/2026
AI Quality Analysis
Trust Score Breakdown
Quick Links
Sivuston kohokohdat
🌟 Vastaavat luotettavat yritykset
vTv Therapeutics Inc.
vTv Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of diabetes patients. They focus on developing oral, small molecule drug candidates. Their lead candidate is cadisegliatin, a potential adjunctive therapy to insulin for type 1 diabetes. They are also exploring indications for type 2 diabetes and other chronic conditions.
Structure Therapeutics Inc.
Based on the provided content, Structure Therapeutics appears to be a company focused on therapeutics. Their website highlights an approach, pipeline, team, career opportunities, and contact information. They also include links to their privacy policy, publications, and terms of use. Further details would be needed to provide a more comprehensive description.
Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics is a clinical-stage biotech company working to harness the power of the immune system to improve lives and eradicate cancer. The company is developing novel immunotherapies using foreign patterns to trigger the innate immune system, which teaches the immune system to recognize and kill cancer. Bolt was founded in 2015.